Patricia McKnight December 16, 2022 A cancer vaccine based on the messenger RNA (mRNA) technology, provided alongside the checkpoint inhibitor pembrolizumab (Keytruda), has shown encouraging results in an open label phase 2b clinical trial. The trial found that the combination regimen reduced the risk of cancer recurrence or death among melanoma patients by 44% compared with pembrolizumab alone, according to the vaccine’s...
Tag: <span>mRNA cancer vaccine</span>
Post
Moderna says personalized mRNA cancer vaccine is effective for advanced melanoma
The company said that in a phase 2 clinical trial, the vaccine, when combined with immunotherapy drug Keytruda, reduced the risk of recurrence by 44%. A Moderna building in Cambridge, Mass., on May 18, 2020.Bill Sikes / AP fileLink copied Dec. 13, 2022, 10:13 AM MSTBy The Associated Press Moderna’s stock soared Tuesday after the Covid-19...
Post
New mRNA cancer vaccine targets lymph nodes for stronger immune response
By Michael Irving August 16, 2022 A new mRNA cancer vaccine is designed to target the lymph nodes to induce a stronger immune response Depositphotos Researchers at Tufts University have created a new mRNA vaccine for cancer that’s designed to carry its cargo to the lymph nodes rather than the liver. Tests in mice showed...